IP Library Granted Patent US 8,357,514
Granted Patent B2
US 8,357,514 · App. 12/593,132 · Granted Jan 22, 2013

Methods of gene amplification and expression

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,357,514
App. No.
12/593,132
Granted
Jan 22, 2013
Kind
B2
Abstract

Disclosed are methods relating to amplification and expression of a nucleic acid sequence encoding a polypeptide of interest in recombinant cells, and cell lines and polypeptides produced from such methods. The methods disclosed herein permit the amplification of cell lines that express a polypeptide of interest in a relatively short period of time through the use of a bioreactor.

Claims (14)

1. A method for producing a recombinant cell line that highly expresses a polypeptide of interest, comprising:

(a) inoculating host cells in a perfusion bioreactor, wherein the host cells are transfected with (i) a nucleic acid sequence encoding a polypeptide of interest and (ii) a nucleic acid sequence encoding an amplifiable marker;

(b) culturing the host cells in the presence of an increasing amount of an amplification agent in the perfusion bioreactor to amplify the nucleic acid sequence encoding a polypeptide of interest in the host cells; and

(c) subcloning the host cells from (b) to produce a cell line that highly expresses a polypeptide of interest.

2. The method of claim 1 wherein the nucleic acid sequence encoding a polypeptide of interest and the nucleic acid sequence encoding an amplifiable marker are contained on a single vector.

3. The method of claim 1 wherein the amplifiable marker encodes a DHFR protein.

4. The method of claim 1 wherein the host cells are mammalian cells.

5. The method of claim 1 wherein the host cells are CHO cells.

6. The method of claim 1 wherein the polypeptide of interest is an antibody.

7. The method of claim 1 wherein the increasing amount of the amplification agent is added to the media when % cell viability is increasing or stable.

8. The method of claim 1 , wherein the host cells are derived from the same single clone.

9. The method of claim 1 , wherein the host cells are pooled multiple clones.

10. The method of claim 1 , wherein the host cells are bulk transfectants.

11. The method of claim 1 , wherein the amplification agent is methotrexate.

Assignments (4)
MERGER Recorded Mar 19, 2015
From: MEDAREX, L.L.C.
To: E. R. SQUIBB & SONS, L.L.C.
Reel/Frame 035226/0690 →
MERGER Recorded Jun 13, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 030603/0924 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2010
From: GHEBRAMARIAM, HAILE
To: MEDAREX, INC.
Reel/Frame 025518/0704 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2010
From: ARUNAKUMARI, ALAHARI; DAI, XIAO-PING
To: MEDAREX, INC.
Reel/Frame 024081/0714 →